Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as "Tregitopes ...

aDepartment of Ophthalmology, University Medical Center Utrecht, University Utrecht, the Netherlands bDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, ...

BRIUMVI is a novel monoclonal antibody that targets a unique epitope on CD20-expressing B-cells. Targeting CD20 using monoclonal antibodies has proven to be an important therapeutic approach for the ...

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple ...

National Center for Competence in Research (NCCR), Molecular Systems Engineering, 4058 Basel, Switzerland ...

In the rapidly evolving field of antibody drug discovery, the ability to efficiently characterize and screen antibodies and antibody drug conjugates (ADCs) is crucial for developing effective ...

Our study is the first to investigate the prevalence and prognostic value of the MOG antibody non-P42 epitope in a large paediatric MOGAD cohort. We found that half of paediatric patients with MOG-Ab ...